Id |
Subject |
Object |
Predicate |
Lexical cue |
T14 |
0-61 |
Sentence |
denotes |
Clinical presentation and laboratory confirmation of the case |
T15 |
62-208 |
Sentence |
denotes |
The first COVID-19 case in Finland was a female Chinese tourist in her 30s, who had left Wuhan on 22 January and arrived in Finland on 23 January. |
T16 |
209-285 |
Sentence |
denotes |
Her first symptoms were a runny nose on 26 January and nausea on 27 January. |
T17 |
286-379 |
Sentence |
denotes |
Because of high fever (39 °C), weakness and cough she sought medical attention on 28 January. |
T18 |
380-594 |
Sentence |
denotes |
Suspicion of COVID-19 led to her direct transfer to the Lapland Central Hospital in Rovaniemi, where she was isolated and sampled on 28 and 29 January for laboratory confirmation of SARS-CoV-2 infection (Figure 1). |
T19 |
595-813 |
Sentence |
denotes |
SARS-CoV-2 infection was confirmed from nasopharyngeal samples on 29 January by the Helsinki University Hospital Laboratory (HUSLAB), and further confirmed at the Finnish Institute for Health and Welfare (THL) (Table). |
T20 |
814-969 |
Sentence |
denotes |
Both laboratories performed real-time RT-PCR testing for three targets: the envelope (E), the RNA-dependent RNA polymerase (RdRp) and the nucleocapsid (N). |
T21 |
970-1032 |
Sentence |
denotes |
Primers and probes were based on the Corman et al. method [2]. |
T22 |
1033-1095 |
Sentence |
denotes |
Cycle threshold (Ct) values above 37 were considered negative. |
T23 |
1096-1198 |
Sentence |
denotes |
Figure 1 Timeline of events around the first COVID-19 case imported to Finland, January–February 2020 |
T24 |
1199-1229 |
Sentence |
denotes |
COVID-19: coronavirus disease. |
T25 |
1230-1326 |
Sentence |
denotes |
Table Laboratory data of the first case of SARS-CoV-2 infection, Finland, January–February 2020 |
T26 |
1327-1417 |
Sentence |
denotes |
Sampling day Day since the first symptoms Specimen PCR done at E RdRp N MN IgM IgG |
T27 |
1418-1487 |
Sentence |
denotes |
28 Jan 2020Day 3 NPS HUSTHL ND30.49 ND30.48 ND31.59 NA NA NA |
T28 |
1488-1568 |
Sentence |
denotes |
29 Jan 2020Day 4 NPA HUSTHL 31.1827.13 27.56 28.43 28.2928.73 NA NA NA |
T29 |
1569-1630 |
Sentence |
denotes |
NPS HUSTHL 28.1529.59 27.1330.87 28.8231.78 NA NA NA |
T30 |
1631-1685 |
Sentence |
denotes |
Serum THLUH NegNeg NegNeg NegNeg < 4 < 20 < 20 |
T31 |
1686-1751 |
Sentence |
denotes |
03 Feb 2020Day 9 NPS HUSTHL NegNeg NegNeg NegNeg NA NA NA |
T32 |
1752-1787 |
Sentence |
denotes |
Serum UH ND Neg Neg 60 80 80 |
T33 |
1788-1854 |
Sentence |
denotes |
04 Feb 2020Day 10 NPS HUSTHL NegNeg NegNeg NegNeg NA NA NA |
T34 |
1855-1890 |
Sentence |
denotes |
Serum ND ND ND ND 72 160 160 |
T35 |
1891-1951 |
Sentence |
denotes |
14 Feb 2020Day 20 Serum UH Neg Neg Neg 160 320 1,280 |
T36 |
1952-2018 |
Sentence |
denotes |
17 Feb 2020Day 23 NPS HUSTHL NegNeg NegNeg NegNeg NA NA NA |
T37 |
2019-2049 |
Sentence |
denotes |
E: envelope protein gene; HUS: |
T38 |
2050-2382 |
Sentence |
denotes |
Helsinki University Hospital Laboratory; IgG: immunoglobulin G; IgM: immunoglobulin M; MN: microneutralisation test; N: nucleocapsid protein gene; NA: not applicable; ND: not done; Neg: negative; NPA: nasopharyngeal aspirate; NPS: nasopharyngeal swab; RdRp: RNA-dependent RNA polymerase gene; RT-PCR: reverse-transcription PCR; THL: |
T39 |
2383-2428 |
Sentence |
denotes |
Finnish Institute for Health and Welfare; UH: |
T40 |
2429-2452 |
Sentence |
denotes |
University of Helsinki. |
T41 |
2453-2512 |
Sentence |
denotes |
The case had mild symptoms throughout the isolation period. |
T42 |
2513-2641 |
Sentence |
denotes |
She was tested PCR-negative in 3 and 4 February samples and, as considered asymptomatic, discharged from hospital on 5 February. |
T43 |
2642-2731 |
Sentence |
denotes |
One additional sample for serology and PCR was taken on 14 and 17 February, respectively. |
T44 |
2732-2803 |
Sentence |
denotes |
Altogether 21 close contacts were identified of whom we could reach 17. |
T45 |
2804-2872 |
Sentence |
denotes |
Fourteen were still in Finland and placed in quarantine for 14 days. |
T46 |
2873-3014 |
Sentence |
denotes |
Information about three close contacts that had left the country was communicated to the competent authorities in their respective countries. |
T47 |
3015-3080 |
Sentence |
denotes |
For the remaining four close contacts, we had no contact details. |
T48 |
3081-3224 |
Sentence |
denotes |
Two of the 21 close contacts were closely co-exposed and therefore sampled on Days 4, 10, 12 and 14 after the first symptoms of the index case. |
T49 |
3225-3310 |
Sentence |
denotes |
Follow-up of all contacts ended on 11 February without secondary transmission events. |